DNA logo

DNA
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

12,791
Mkt Cap
$502.99M
Volume
2.96M
52W High
$17.58
52W Low
$5.00
PE Ratio
-1.53
DNA Fundamentals
Price
$8.95
Prev Close
$11.30
Open
$10.29
50D MA
$12.61
Beta
2.59
Avg. Volume
1.58M
EPS (Annual)
-$10.54
P/B
0.77
Rev/Employee
$272,233.81
Loading...
Loading...
News
all
press releases
Ginkgo Bioworks Holdings Q3 Loss Widens
(RTTNews) - Ginkgo Bioworks Holdings, Inc. (DNA) on Thursday reported third-quarter net loss of $80.76 million or $1.45 per share, compared to $56.40 million or $1.08 per share in the comparable...
Nasdaq News: Markets·2d ago
News Placeholder
More News
News Placeholder
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results Ginkgo Bioworks Reports Third Quarter 2025 Financial Results PR Newswire BOSTON, Nov. 6, 2025 Ginkgo provides an update on its third...
PR Newswire·2d ago
News Placeholder
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership...
PR Newswire·8d ago
News Placeholder
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation PR Newswire BOSTON, Oct. 30, 2025 Presentation and...
PR Newswire·9d ago
News Placeholder
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts
Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $12.74, signifying a -4.85% move from its prior day's close.
Zacks·11d ago
News Placeholder
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program Ginkgo Bioworks in Partnership with STRM.BIO...
PR Newswire·16d ago
News Placeholder
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.78, marking a -2.67% move from the previous day.
Zacks·17d ago
News Placeholder
The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners
The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners The Institute for Follicular...
PR Newswire·18d ago
News Placeholder
Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know
In the most recent trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $15.12, indicating a -4.49% shift from the previous trading day.
Zacks·23d ago
News Placeholder
Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note
Ginkgo Bioworks Holdings, Inc. (DNA) reached $15.24 at the closing of the latest trading day, reflecting a -5.28% change compared to its last close.
Zacks·30d ago

Latest DNA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.